These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 9916516)
21. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V; Kalita J; Misra UK Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647 [TBL] [Abstract][Full Text] [Related]
22. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis. Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452 [TBL] [Abstract][Full Text] [Related]
23. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases. Boukhris S; Magy L; Gallouedec G; Khalil M; Couratier P; Gil J; Vallat JM J Peripher Nerv Syst; 2005 Sep; 10(3):329-37. PubMed ID: 16221292 [TBL] [Abstract][Full Text] [Related]
24. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Dyck PJ; Litchy WJ; Kratz KM; Suarez GA; Low PA; Pineda AA; Windebank AJ; Karnes JL; O'Brien PC Ann Neurol; 1994 Dec; 36(6):838-45. PubMed ID: 7998769 [TBL] [Abstract][Full Text] [Related]
25. [Immune-mediated neuropathies: indications and value of nerve biopsy]. Verschueren A Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231 [TBL] [Abstract][Full Text] [Related]
26. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature. Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859 [TBL] [Abstract][Full Text] [Related]
27. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Krendel DA; Parks HP; Anthony DC; St Clair MB; Graham DG Muscle Nerve; 1989 Apr; 12(4):257-64. PubMed ID: 2770778 [TBL] [Abstract][Full Text] [Related]
28. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy? Oh SJ; Claussen GC; Kim DS J Peripher Nerv Syst; 1997; 2(4):362-9. PubMed ID: 10975745 [TBL] [Abstract][Full Text] [Related]
29. [Value of proximal conduction block study in diagnosis of inflammatory neuropathies]. Jaspert A; Claus D; Grehl H; Kerling F; Neundörfer B Nervenarzt; 1995 Jun; 66(6):445-54. PubMed ID: 7637830 [TBL] [Abstract][Full Text] [Related]
30. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis]. Tagawa Y; Yuki N Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330 [TBL] [Abstract][Full Text] [Related]
31. The Mayo Clinic experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP). Dyck PJ; Pineda A; Swanson C; Low P; Windebank A; Daube J Prog Clin Biol Res; 1982; 106():197-204. PubMed ID: 6757940 [TBL] [Abstract][Full Text] [Related]
32. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Van den Bergh PY; Piéret F Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622 [TBL] [Abstract][Full Text] [Related]
33. Chronic inflammatory demyelinating polyradiculoneuropathy with autonomic involvement. Yamamoto K; Watarai M; Hashimoto T; Ikeda S Muscle Nerve; 2005 Jan; 31(1):108-12. PubMed ID: 15389651 [TBL] [Abstract][Full Text] [Related]
34. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy. Pineda AA; Ogata K; Osoegawa M; Murai H; Shigeto H; Yoshiura T; Tobimatsu S; Kira J J Neurol Sci; 2007 Apr; 255(1-2):1-6. PubMed ID: 17306302 [TBL] [Abstract][Full Text] [Related]
35. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy. Harbo T; Andersen H; Jakobsen J Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356 [TBL] [Abstract][Full Text] [Related]
36. Double filtration plasmapheresis can decrease factor XIII Activity. Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996 [TBL] [Abstract][Full Text] [Related]
37. [Chronic inflammatory demyelinating polyradiculoneuropathy presenting localized radiculopathy as an initial symptom]. Kuwabara S; Kawamura M; Nagumo K; Kitano K; Hirayama K Rinsho Shinkeigaku; 1991 Mar; 31(3):310-3. PubMed ID: 1893672 [TBL] [Abstract][Full Text] [Related]
38. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435 [TBL] [Abstract][Full Text] [Related]
39. [CIDP: diagnostic strategy when electromyography is not contributive]. Denys V Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S54-7. PubMed ID: 18087230 [TBL] [Abstract][Full Text] [Related]
40. Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy. Matsuda M; Hoshi K; Gono T; Morita H; Ikeda S J Neurol Sci; 2004 Sep; 224(1-2):29-35. PubMed ID: 15450768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]